Federal fact file dated September 26, 2026.
Peptide is a word, not a treatment plan
Before comparing places, get the name of the thing being offered. A broad label leaves too much unsaid.
Name the ingredient before the package
The FDA is the U.S. Food and Drug Administration, which reviews medicines for approval.
Insulin is a peptide, but the word peptide alone does not settle whether a product is lawful or safe.
Read the FDA’s product and compounding distinctions
Have the product’s complete name written down. Would it be a cream, a tablet, an injection or something else? What is it meant to treat? Bring those answers to the next conversation.
If you are offered a vitamin drip into a vein (IV), hormone care, lasers or other treatments, ask for a separate explanation of each.
Keep the product categories apart
U.S. law treats these groups differently: approved medicines, medicines prepared to order under compounding rules, and new medicines without approval.
Read the rules for these groups of medicines
Do not settle for a treatment menu as the answer. Ask which category the exact product belongs to, and ask to see the record behind that answer.
Ask about the route as well as the name
A peptide in a cosmetic cream and a product intended for injection are subject to different rules.
Read how FDA distinguishes cosmetic and drug uses
Research on a cream leaves the injection question unanswered.
Beside the medicine’s name, write how it would be given. That small detail keeps the discussion tied to the offer in front of you.
